Emilie Eiselt

Sherbrooke, QC J1H5N4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ligand-dependent intracellular trafficking of the G protein-coupled P2Y6 receptor.

Ligand-dependent intracellular trafficking of the G protein-coupled P2Y6 receptor.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: September 26, 2022

Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.

Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.

Journal: Journal of medicinal chemistry

Published: September 09, 2020

The P2Y6 receptor signals through Gαq /Ca2+ /PKCα and Gα13 /ROCK pathways to drive the formation of membrane protrusions and dictate cell migration.

The P2Y6 receptor signals through Gαq /Ca2+ /PKCα and Gα13 /ROCK pathways to drive the formation of membrane protrusions and dictate cell migration.

Journal: Journal of cellular physiology

Published: January 09, 2020

Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.

Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.

Journal: The Journal of pharmacology and experimental therapeutics

Published: November 03, 2019

Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.

Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.

Journal: ACS chemical neuroscience

Published: October 08, 2019

The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.

The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.

Journal: European journal of pharmacology

Published: October 22, 2018

Corrigendum to "Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings" [Bioorg. Med. Chem. Lett. 28(13) (2018) 2320-2323].

Corrigendum to "Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings" [Bioorg. Med. Chem. Lett. 28(13) (2018) 2320-2323].

Journal: Bioorganic & medicinal chemistry letters

Published: September 10, 2018

Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings.

Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings.

Journal: Bioorganic & medicinal chemistry letters

Published: April 09, 2018

χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds.

χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds.

Journal: ACS medicinal chemistry letters

Published: August 23, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026